Matrix Attachment Region Binding Proteins
"Matrix Attachment Region Binding Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that bind to the MATRIX ATTACHMENT REGIONS of DNA.
| Descriptor ID |
D036961
|
| MeSH Number(s) |
D12.776.260.532
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Matrix Attachment Region Binding Proteins".
Below are MeSH descriptors whose meaning is more specific than "Matrix Attachment Region Binding Proteins".
This graph shows the total number of publications written about "Matrix Attachment Region Binding Proteins" by people in this website by year, and whether "Matrix Attachment Region Binding Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Attachment Region Binding Proteins" by people in Profiles.
-
Cytohistologic Diagnosis of Rosette-Forming Epithelioid Osteosarcoma. Diagn Cytopathol. 2026 Mar; 54(3):E63-E66.
-
Pathogenic SATB2 missense variants affecting p.Gly392 have variable functional implications and result in diverse clinical phenotypes. J Med Genet. 2024 Oct 23; 61(11):1062-1067.
-
PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework. Nat Genet. 2023 09; 55(9):1598-1607.
-
Mutation-specific pathophysiological mechanisms define different neurodevelopmental disorders associated with SATB1 dysfunction. Am J Hum Genet. 2021 02 04; 108(2):346-356.
-
Immunohistochemical Expression of CDX2 and SATB2 in Primary Breast Carcinomas. Appl Immunohistochem Mol Morphol. 2020 07; 28(6):e53.
-
Epilepsy and Electroencephalographic Abnormalities in SATB2-Associated Syndrome. Pediatr Neurol. 2020 11; 112:94-100.
-
Mutation update for the SATB2 gene. Hum Mutat. 2019 08; 40(8):1013-1029.
-
Increased bone turnover, osteoporosis, progressive tibial bowing, fractures, and scoliosis in a patient with a final-exon SATB2 frameshift mutation. Am J Med Genet A. 2016 11; 170(11):3028-3032.
-
Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy. PLoS One. 2013; 8(2):e56730.
-
SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells. J Biol Chem. 2010 Feb 05; 285(6):3608-3616.